Home > Search Results: Dziadziuszko, R.
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
10 p, 367.0 KB ESMO Management and treatment adapted recommendations in the COVID-19 era : Lung cancer / Passaro, Antonio (IRCCS European Institute of Oncology (Milà, Itàlia)) ; Addeo, Alfredo (Geneva University Hospitals (Suïssa)) ; Von Garnier, Christophe (Centre Hospitalier Universitaire Vaudois) ; Blackhall, Fiona (University of Manchester) ; Planchard, David (Gustave Roussy) ; Felip, Enriqueta (Vall d'Hebron Institut d'Oncologia) ; Dziadziuszko, Rafal (Gdanski Uniwersytet Medyczny) ; De Marinis, Filippo (IRCCS European Institute of Oncology (Milà, Itàlia)) ; Reck, Martin (LungenClinic) ; Bouchaab, Hasna (Centre Hospitalier Universitaire Vaudois) ; Peters, Solange (Centre Hospitalier Universitaire Vaudois) ; Universitat Autònoma de Barcelona
The COVID-19 pandemic, characterised by a fast and global spread during the first months of 2020, has prompted the development of a structured set of recommendations for cancer care management, to maintain the highest possible standards. [...]
2020 - 10.1136/esmoopen-2020-000820
ESMO open, Vol. 5 (january 2020)  
Detailed record - Creative Commons
2.
10 p, 290.8 KB Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer / Peters, S. (Lausanne University Hospital) ; Camidge, David Ross (University of Colorado) ; Shaw, A. T. (Massachusetts General Hospital (Boston)) ; Gadgeel, S. (University of Michigan) ; Ahn, Jin Seop (Samsung Medical Center. Sungkyunkwan University School of Medicine) ; Kim, Dong-Wan (Seoul National University Hospital) ; Ou, S. H. I. (School of Medicine) ; Pérol, M. (Department of Medical Oncology. Léon Bérard Cancer Center) ; Dziadziuszko, R. (Department of Oncology and Radiotherapy. Medical University of Gdansk) ; Rosell, R. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Zeaiter, A. (F. Hoffmann-La Roche) ; Mitry, E. (F. Hoffmann-La Roche) ; Golding, S. (F. Hoffmann-La Roche) ; Balas, B. (F. Hoffmann-La Roche) ; Noe, J. (F. Hoffmann-La Roche) ; Morcos, P. N. (Roche Innovation Center) ; Mok, T. (State Key Laboratory of South China. Chinese University of Hong Kong)
BACKGROUND: Alectinib, a highly selective inhibitor of anaplastic lymphoma kinase (ALK), has shown systemic and central nervous system (CNS) efficacy in the treatment of ALK-positive non-small-cell lung cancer (NSCLC). [...]
2017 - 10.1056/NEJMoa1704795
The New England journal of medicine, Vol. 377 Núm. 9 (31 2017) , p. 829-838  
Detailed record -

See also: similar author names
1 Dziadziuszko, Rafal
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with